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Recently, Raymond Reif and colleagues 
from the Leibniz Research Center in Dort-
mund have published a technical article about 
two-photon based intravital imaging (Reif et 
al., 2016). The strength of this article is the 
outstanding quality of the presented videos, 
which show organs of living mice, namely 
liver, kidney and intestine, with a resolution 
of approximately 200 nm. Key features of the 
established imaging technique are two-pho-
ton lasers with a broad wavelength spectrum, 
long-distance objectives with high numerical 
aperture, a sensitive detector and an opti-
mized anesthesia (Reif et al., 2016). Under 
these conditions the technique can be applied 
to multiple organs to study transport and elim-
ination of xenobiotics and endogenous com-
pounds.  A fundamental prerequisite of in-
travital imaging is the use of appropriate 
fluorophore-coupled compounds and fluores-
cent reporter mice. The authors used this 
method to image and quantify the flux of flu-
orescent bile salts and drugs from the sinus-
oids of the liver through the Dissé space into 
hepatocytes and finally into bile canaliculi. In 
the kidney it was possible to analyze glomer-
ular filtration into the Bowman´s capsule fol-
lowed by transport into the proximal and then 
to the distal tubules. After bolus injections of 
fluorescent compounds even the passage time 
from proximal to distal tubules via the Henle 
loop could be determined. Finally, the same 
approach was used to image intestinal crypts 
and study the transfer of drugs from capillar-
ies to lymph vessels. 
The presented intravital technique has 
major implications for three fields of re-
search. First, pharmacokinetic modelling can 
be improved by intravital imaging. PBPK 
modelling is of high relevance for simulation 
of compound concentrations in blood or or-
gans (Golubovskaya et al., 2015; Stamyr et 
al., 2015; Widera, 2015; Ghallab, 2015) as 
well as for interspecies extrapolation (Thiel et 
al., 2015). However, current PBPK models 
consider individual organs as single compart-
ments (Schug et al., 2013; Mielke et al., 
2011). Using intravital microscopy it became 
clear that sub-compartments of tissues may 
accumulate specific compounds. Integrating 
these dynamics into PBPK models may fur-
ther improve simulations. Second, establish-
ment of in vitro systems represents a cutting-
edge topic (Ghallab and Bolt, 2014; Godoy et 
al., 2013; Krug et al., 2013), particularly in 
the fields of cell systems for hepatotoxicity 
(Reif et al., 2015; Böttger et al., 2015; Grin-
berg et al., 2014), nephrotoxicity (Wasser-
mann et al., 2013; Valente et al., 2012; 
Buhrke et al., 2015) and intestinal transport 
(Niu et al., 2015). It is important to be aware 
of similarities but also differences of these 
cultivated cells to their in vivo counterparts. 
Two-photon imaging can be used to study 
compound transport in vitro and in vivo by 
precisely the same method. Third, spatio-tem-
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poral modelling has become a well-estab-
lished technique in systems biology (Drasdo 
et al., 2014a, b; Ghallab et al., 2016; Hammad 
et al., 2014). A basic principle of spatio-tem-
poral modelling is that tissues are recon-
structed in a way that the position of each cell 
in a three-dimensional space is known; next 
further processes of interest, e.g. metabolic 
models, can be programmed into each indi-
vidual cell to simulate the consequences at the 
tissue level (Hoehme et al., 2010; Schliess et 
al., 2014). Two-photon based imaging repre-
sents an excellent technique to validate pre-
dictions from spatio-temporal tissue models. 
In conclusion, the two-photon based im-
aging technique presented by Reif and col-
leagues will support spatio-temporal model-
ling studies of physiological and pathophysi-
ological processes in all organs of interest.       
 
REFERENCES 
Böttger J, Arnold K, Thiel C, Rennert C, Aleithe S, 
Hofmann U, et al. RNAi in murine hepatocytes: the ag-
ony of choice--a study of the influence of lipid-based 
transfection reagents on hepatocyte metabolism. Arch 
Toxicol. 2015;89:1579-88. 
Buhrke T, Frenzel F, Kuhlmann J, Lampen A. 2-
Chloro-1,3-propanediol (2-MCPD) and its fatty acid 
esters: cytotoxicity, metabolism, and transport by hu-
man intestinal Caco-2 cells. Arch Toxicol. 2015;89: 
2243-51. 
Drasdo D, Bode J, Dahmen U, Dirsch O, Dooley S, 
Gebhardt R, et al. The virtual liver: state of the art and 
future perspectives. Arch Toxicol. 2014a;88:2071-5. 
Drasdo D, Hoehme S, Hengstler JG. How predictive 
quantitative modelling of tissue organisation can in-
form liver disease pathogenesis. J Hepatol. 2014b;61: 
951-6. 
Ghallab A. Systems toxicology. EXCLI J. 2015;14: 
1267-9. 
Ghallab A, Bolt HM. In vitro systems: current limita-
tions and future perspectives. Arch Toxicol. 2014;88: 
2085-7.  
Ghallab A, Cellière G, Henkel SG, Driesch D, Hoehme 
S, Hofmann U, et al. Model-guided identification of a 
therapeutic strategy to reduce hyperammonemia in 
liver diseases. J Hepatol. 2016;64:860-71. 
Godoy P, Hewitt NJ, Albrecht U, Andersen ME, An-
sari N, Bhattacharya S, et al. Recent advances in 2D 
and 3D in vitro systems using primary hepatocytes, al-
ternative hepatocyte sources and non-parenchymal 
liver cells and their use in investigating mechanisms of 
hepatotoxicity, cell signaling and ADME. Arch Toxi-
col. 2013;87:1315-530. 
Golubovskaya V, Curtin L, Groman A, Sexton S, 
Cance WG. In vivo toxicity, metabolism and pharma-
cokinetic properties of FAK inhibitor 14 or Y15 (1, 2, 
4, 5-benzenetetramine tetrahydrochloride). Arch Toxi-
col. 2015;89:1095-101. 
Grinberg M, Stöber RM, Edlund K, Rempel E, Godoy 
P, Reif R, et al. Toxicogenomics directory of chemi-
cally exposed human hepatocytes. Arch Toxicol. 
2014;88:2261-87. 
Hammad S, Hoehme S, Friebel A, von Recklinghausen 
I, Othman A, Begher-Tibbe B, et al. Protocols for stain-
ing of bile canalicular and sinusoidal networks of hu-
man, mouse and pig livers, three-dimensional recon-
struction and quantification of tissue microarchitecture 
by image processing and analysis. Arch Toxicol. 
2014;88:1161-83. 
Hoehme S, Brulport M, Bauer A, Bedawy E, Schor-
mann W, Hermes M, et al. Prediction and validation of 
cell alignment along microvessels as order principle to 
restore tissue architecture in liver regeneration. Proc 
Natl Acad Sci USA. 2010;107:10371-6. 
Krug AK, Kolde R, Gaspar JA, Rempel E, Balmer NV, 
Meganathan K, et al. Human embryonic stem cell-de-
rived test systems for developmental neurotoxicity: a 
transcriptomics approach. Arch Toxicol. 2013; 87:123-
43. 
Mielke H, Anger LT, Schug M, Hengstler JG, Stahl-
mann R, Gundert-Remy U. A physiologically based 
toxicokinetic modelling approach to predict relevant 
concentrations for in vitro testing. Arch Toxicol. 
2011;85:555-63. 
Niu X, de Graaf IA, Langelaar-Makkinje M, Horvato-
vich P, Groothuis GM. Diclofenac toxicity in human 
intestine ex vivo is not related to the formation of in-
testinal metabolites. Arch Toxicol. 2015;89:107-19. 
Reif R, Karlsson J, Günther G, Beattie L, Wrangborg 
D, Hammad S, et al. Bile canalicular dynamics in 
hepatocyte sandwich cultures. Arch Toxicol. 2015; 
89:1861-70. 
EXCLI Journal 2016;15:872-874 – ISSN 1611-2156 
Received: December 11, 2016, accepted: December 20, 2016, published: December 23, 2016 
 
 
874 
Reif R, Ghallab A, Beattie L, Günther G, Kuepfer L, 
Kaye PM, et al. In vivo imaging of systemic transport 
and elimination of xenobiotics and endogenous mole-
cules in mice. Arch Toxicol. 2016 Dec 20.    
doi: 10.1007/s00204-016-1906-5. [Epub ahead of 
print] 
Schliess F, Hoehme S, Henkel SG, Ghallab A, Driesch 
D, Böttger J, et al. Integrated metabolic spatial-tem-
poral model for the prediction of ammonia detoxifica-
tion during liver damage and regeneration. Hepatol-
ogy. 2014;60:2040-51. 
Schug M, Stöber R, Heise T, Mielke H, Gundert-Remy 
U, Godoy P, et al. Pharmacokinetics explain in vivo/in 
vitro discrepancies of carcinogen-induced gene expres-
sion alterations in rat liver and cultivated hepatocytes. 
Arch Toxicol. 2013;87:337-45. 
Stamyr K, Mörk AK, Johanson G. Physiologically 
based pharmacokinetic modeling of hydrogen cyanide 
levels in human breath. Arch Toxicol. 2015;89:1287-
96. 
Thiel C, Schneckener S, Krauss M, Ghallab A, Hof-
mann U, Kanacher T, et al. A systematic evaluation of 
the use of physiologically based pharmacokinetic mod-
eling for cross-species extrapolation. J Pharm Sci. 
2015;104:191-206. 
Valente MJ, Henrique R, Vilas-Boas V, Silva R, 
Bastos Mde L, Carvalho F, et al. Cocaine-induced kid-
ney toxicity: an in vitro study using primary cultured 
human proximal tubular epithelial cells. Arch Toxicol. 
2012;86:249-61. 
Wassermann L, Halwachs S, Baumann D, Schaefer I, 
Seibel P, Honscha W. Assessment of ABCG2-medi-
ated transport of xenobiotics across the blood-milk bar-
rier of dairy animals using a new MDCKII in vitro 
model. Arch Toxicol. 2013;87:1671-82. 
Widera A. Highlight report: Interspecies extrapolation 
by physiologically based pharmacokinetic modeling. 
EXCLI J. 2015;14:1014-6. 
 
 
